Sichuan Kelun Pharmaceutical Co Ltd Capital Reinvestment Ratio
Sichuan Kelun Pharmaceutical Co Ltd capital reinvestment ratio. Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Capital Reinvestment Ratio of 0.73x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥537.31 Million) in capital expenditures (CN¥393.58 Million). See 002422 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Capital reinvestment ratio of Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. This chart tracks Sichuan Kelun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods. See Sichuan Kelun Pharmaceutical Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Sichuan Kelun Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2007–2025)
Sichuan Kelun Pharmaceutical Co Ltd capital reinvestment ratio by year from 2007 to 2025. For the full cash flow conversion analysis, see Sichuan Kelun Pharmaceutical Co Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.61x | CN¥2.64 Billion | CN¥1.62 Billion | ▲ +64.4% |
| 2024 | 0.37x | CN¥4.49 Billion | CN¥1.68 Billion | ▲ +12.7% |
| 2023 | 0.33x | CN¥5.34 Billion | CN¥1.77 Billion | ▲ +15.7% |
| 2022 | 0.29x | CN¥3.13 Billion | CN¥896.02 Million | ▼ -17.7% |
| 2021 | 0.35x | CN¥2.85 Billion | CN¥990.56 Million | ▼ -37.3% |
| 2020 | 0.55x | CN¥2.22 Billion | CN¥1.23 Billion | ▼ -7.6% |
| 2019 | 0.60x | CN¥2.22 Billion | CN¥1.33 Billion | ▲ +33.4% |
| 2018 | 0.45x | CN¥2.95 Billion | CN¥1.33 Billion | ▼ -63.3% |
| 2017 | 1.23x | CN¥1.20 Billion | CN¥1.48 Billion | ▲ +54.7% |
| 2016 | 0.79x | CN¥1.73 Billion | CN¥1.37 Billion | ▼ -46.5% |
| 2015 | 1.48x | CN¥1.24 Billion | CN¥1.84 Billion | ▼ -34.4% |
| 2014 | 2.26x | CN¥1.22 Billion | CN¥2.76 Billion | ▲ +5.2% |
| 2013 | 2.15x | CN¥1.05 Billion | CN¥2.26 Billion | ▼ -68.8% |
| 2012 | 6.89x | CN¥402.77 Million | CN¥2.77 Billion | ▲ +17.8% |
| 2011 | 5.85x | CN¥342.93 Million | CN¥2.00 Billion | ▲ +34.8% |
| 2010 | 4.34x | CN¥149.29 Million | CN¥647.22 Million | ▲ +294.8% |
| 2009 | 1.10x | CN¥250.69 Million | CN¥275.29 Million | ▲ +7.1% |
| 2008 | 1.02x | CN¥221.08 Million | CN¥226.58 Million | ▼ -1.4% |
| 2007 | 1.04x | CN¥168.42 Million | CN¥175.05 Million | — |